ERBB2 and breast cancer: Based on the receptor patterns of genomic expression profiling, breast cancer is classified into four major classes: luminal A, luminal B, human epidermal growth factor receptor-2 (HER2)-positive, and triple-negative breast cancer (TNBC) [10,11].